Quantcast PEGASYS(R)/COPEGUS(R) Show Benefit In Hard-To-Treat Latino Population With Hepatitis - Congoo
 
 
Log In
PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis
Have an interest in this Story?
Sign Up for Real-Time email updates
Forbes.com  | May 18, 2008

SAN DIEGO, Calif., May 18 /PRNewswire/ -- Roche today announced results from the LATINO study, the largest prospective study to evaluate the response of Latino whites infected with genotype 1 hepatitis C virus (HCV) to combination therapy with pegylated interferon plus ribavirin. The results showed ...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Niladri Roy Niladri Roy
Manager-International Marketing
Computer Services
Martin P. Lee Martin P. Lee
Mr
Knowledge Management

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.